Annual Net Income
$1.13 B
+$1.09 B+2549.50%
December 31, 2023
Summary
- As of February 10, 2025, RPRX annual net profit is $1.13 billion, with the most recent change of +$1.09 billion (+2549.50%) on December 31, 2023.
- During the last 3 years, RPRX annual net income has risen by +$159.79 million (+16.39%).
- RPRX annual net income is now -51.68% below its all-time high of $2.35 billion, reached on December 31, 2019.
Performance
RPRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
$543.99 M
+$441.98 M+433.30%
September 30, 2024
Summary
- As of February 10, 2025, RPRX quarterly net profit is $543.99 million, with the most recent change of +$441.98 million (+433.30%) on September 30, 2024.
- Over the past year, RPRX quarterly net income has increased by +$539.21 million (+11285.24%).
- RPRX quarterly net income is now -61.70% below its all-time high of $1.42 billion, reached on December 31, 2019.
Performance
RPRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
$1.15 B
+$471.87 M+70.09%
September 30, 2024
Summary
- As of February 10, 2025, RPRX TTM net profit is $1.15 billion, with the most recent change of +$471.87 million (+70.09%) on September 30, 2024.
- Over the past year, RPRX TTM net income has increased by +$346.25 million (+43.34%).
- RPRX TTM net income is now -51.24% below its all-time high of $2.35 billion, reached on December 31, 2019.
Performance
RPRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RPRX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2549.5% | +10000.0% | +43.3% |
| 3 y3 years | +16.4% | +10000.0% | +43.3% |
| 5 y5 years | -17.6% | +33.0% | -51.2% |
RPRX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2549.5% | at high | +219.3% | at high | +2573.5% |
| 5 y | 5-year | -51.7% | +2549.5% | -61.7% | +219.3% | -51.2% | +2573.5% |
| alltime | all time | -51.7% | +2549.5% | -61.7% | +219.3% | -51.2% | +2573.5% |
Royalty Pharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $543.99 M(+433.3%) | $1.15 B(+70.1%) |
| Jun 2024 | - | $102.00 M(+2034.9%) | $673.24 M(-15.7%) |
| Mar 2024 | - | $4.78 M(-99.0%) | $798.86 M(-29.6%) |
| Dec 2023 | $1.13 B(+2549.5%) | $494.34 M(+585.5%) | $1.13 B(+515.4%) |
| Sep 2023 | - | $72.11 M(-68.3%) | $184.41 M(-27.7%) |
| Jun 2023 | - | $227.63 M(-33.2%) | $254.95 M(-23.2%) |
| Mar 2023 | - | $340.75 M(-174.7%) | $331.83 M(+674.7%) |
| Dec 2022 | $42.83 M(-93.1%) | -$456.08 M(-419.7%) | $42.83 M(-91.5%) |
| Sep 2022 | - | $142.65 M(-53.2%) | $506.82 M(+8.7%) |
| Jun 2022 | - | $304.50 M(+488.3%) | $466.10 M(-22.6%) |
| Mar 2022 | - | $51.76 M(+554.9%) | $602.37 M(-2.8%) |
| Dec 2021 | $619.73 M | $7.90 M(-92.2%) | $619.73 M(-20.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $101.93 M(-76.9%) | $782.92 M(-19.4%) |
| Jun 2021 | - | $440.78 M(+537.7%) | $971.62 M(-0.1%) |
| Mar 2021 | - | $69.12 M(-59.6%) | $972.92 M(-0.2%) |
| Dec 2020 | $975.04 M(-58.5%) | $171.09 M(-41.1%) | $975.04 M(-56.2%) |
| Sep 2020 | - | $290.63 M(-34.3%) | $2.22 B(-5.1%) |
| Jun 2020 | - | $442.07 M(+520.5%) | $2.34 B(+14.1%) |
| Mar 2020 | - | $71.24 M(-95.0%) | $2.05 B(-12.6%) |
| Dec 2019 | $2.35 B(+70.5%) | $1.42 B(+247.3%) | $2.35 B(+153.0%) |
| Sep 2019 | - | $408.98 M(+169.6%) | $928.14 M(+78.8%) |
| Jun 2019 | - | $151.71 M(-58.7%) | $519.16 M(+41.3%) |
| Mar 2019 | - | $367.44 M | $367.44 M |
| Dec 2018 | $1.38 B(+13.9%) | - | - |
| Dec 2017 | $1.21 B | - | - |
FAQ
- What is Royalty Pharma annual net profit?
- What is the all time high annual net income for Royalty Pharma?
- What is Royalty Pharma annual net income year-on-year change?
- What is Royalty Pharma quarterly net profit?
- What is the all time high quarterly net income for Royalty Pharma?
- What is Royalty Pharma quarterly net income year-on-year change?
- What is Royalty Pharma TTM net profit?
- What is the all time high TTM net income for Royalty Pharma?
- What is Royalty Pharma TTM net income year-on-year change?
What is Royalty Pharma annual net profit?
The current annual net income of RPRX is $1.13 B
What is the all time high annual net income for Royalty Pharma?
Royalty Pharma all-time high annual net profit is $2.35 B
What is Royalty Pharma annual net income year-on-year change?
Over the past year, RPRX annual net profit has changed by +$1.09 B (+2549.50%)
What is Royalty Pharma quarterly net profit?
The current quarterly net income of RPRX is $543.99 M
What is the all time high quarterly net income for Royalty Pharma?
Royalty Pharma all-time high quarterly net profit is $1.42 B
What is Royalty Pharma quarterly net income year-on-year change?
Over the past year, RPRX quarterly net profit has changed by +$539.21 M (+11285.24%)
What is Royalty Pharma TTM net profit?
The current TTM net income of RPRX is $1.15 B
What is the all time high TTM net income for Royalty Pharma?
Royalty Pharma all-time high TTM net profit is $2.35 B
What is Royalty Pharma TTM net income year-on-year change?
Over the past year, RPRX TTM net profit has changed by +$346.25 M (+43.34%)